|
Market Closed -
Australian S.E.
00:10:10 2026-11-09 EST
|
5-day change | 1st Jan Change | ||
| 0.4500 AUD | +1.12% |
|
+3.45% | +25.00% |
| Market Cap | 213M 147M 132M 120M 110M 207M 13.8B 1.45B 578M 7.36B 551M 539M 23.25B | P/E 2027 * |
-14.8x | P/E 2028 * | 98.9x |
|---|---|---|---|---|---|
| Enterprise Value | 186M 128M 115M 105M 95.82M 181M 12.04B 1.27B 505M 6.42B 481M 470M 20.28B | EV / Sales 2027 * |
29.6x | EV / Sales 2028 * | 6.66x |
| Free-Float |
64.79% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| SPL | Delayed | |
OTC Markets
| SPHRF | Delayed | |
|
Deutsche Boerse AG
| PQ6 | Delayed | |
|
Börse Stuttgart
| PQ6 | Delayed | |
|
Boerse Muenchen
| PQ6 | Real-time | |
|
Berne S.E.
| PQ6 | End-of-day quote |
| 1 day | +1.12% | ||
| 1 week | +3.45% | ||
| 1 month | -46.75% | ||
| 3 months | -43.40% | ||
| 6 months | -38.78% | ||
| Current year | +25.00% |
| 1 week | 0.44 |  | 0.48 |
| 1 month | 0.42 | | 0.86 |
| Current year | 0.33 | | 0.88 |
| 1 year | 0.32 | | 0.88 |
| 3 years | 0.08 | | 0.88 |
| 5 years | 0.08 | | 1.38 |
| 10 years | 0.08 | | 2.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | 2024-01-07 |
Justin Cahill
DFI | Director of Finance/CFO | - | 2023-04-02 |
Jeremy Paull
CTO | Chief Tech/Sci/R&D Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Thomas
CHM | Chairman | 81 | 2014-06-12 |
David McIntyre
BRD | Director/Board Member | 55 | 2020-02-29 |
Lynda Cheng
BRD | Director/Board Member | - | 2021-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Expiration | Chief Executive Officer | -702,768 | 0.1473% | ||
| 8/11/26 | Buy | Chairman | 350,001 | 0.0734% | ||
| 8/11/26 | Buy | Director | 22,741 | 0.0048% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.12% | +3.45% | +32.35% | +221.43% | 147M | |
| -0.79% | -4.48% | +46.48% | +118.69% | 1,206B | |
| +1.43% | +1.11% | +48.05% | +83.72% | 665B | |
| +1.07% | -1.21% | +32.92% | +105.10% | 515B | |
| -0.36% | -3.25% | +45.42% | +63.89% | 381B | |
| -0.14% | -1.87% | +70.06% | +40.55% | 362B | |
| -0.78% | -0.52% | +30.47% | +56.79% | 307B | |
| -0.80% | -0.21% | +7.98% | +36.97% | 289B | |
| +0.03% | -1.20% | +43.79% | +68.49% | 249B | |
| -0.41% | -2.22% | +40.43% | +114.24% | 207B | |
| Average | +0.04% | -1.50% | +39.80% | +90.99% | 417.99B | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.71% | +86.31% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 6.3M 4.33M 3.89M 3.55M 3.24M 6.11M 407M 42.8M 17.07M 217M 16.26M 15.91M 686M | 26.25M 18.05M 16.19M 14.8M 13.51M 25.45M 1.7B 178M 71.12M 905M 67.76M 66.3M 2.86B |
| Net income | -16.25M -11.18M -10.02M -9.16M -8.36M -15.75M -1.05B -110M -44.03M -561M -41.95M -41.05M -1.77B | 1.71M 1.17M 1.05M 962K 878K 1.66M 110M 11.6M 4.63M 58.88M 4.41M 4.31M 186M |
| Net Debt | -27.25M -18.74M -16.81M -15.36M -14.02M -26.42M -1.76B -185M -73.84M -940M -70.35M -68.84M -2.97B | -38.53M -26.5M -23.77M -21.72M -19.83M -37.35M -2.49B -262M -104M -1.33B -99.46M -97.32M -4.2B |
Employees
50
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-09 | A$0.4500 | +1.12% | 319,305 |
| 26-11-06 | A$0.4450 | -3.26% | 523,642 |
| 26-11-05 | A$0.4600 | +1.10% | 890,979 |
| 26-11-04 | A$0.4550 | 0.00% | 1,013,986 |
| 26-11-03 | A$0.4550 | +4.60% | 890,748 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4450AUD
Average target price
1.220AUD
Spread / Average Target
+174.16%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
